Menu

ImmunityBio, Inc. IBRX

Full chart Compare
Set alert

Price alert · IBRX

All alert types
6.67 USD -0.08 (-1.11%)

At closeNov 11, 2026, 7:48 PM EST

6.63 -0.04 -0.60%

After hours · Nov 11, 7:48 PM ET

6.51 Day range 6.85
1.95 52-week range 12.43
YTD
+236.87%
1 year
+211.68%

Discussion (3500)

Sign in to join the discussion

frank fager IBRX 4 months ago #891

Thanks

Paul Silberberg your posts are top drawer

frank fager IBRX 4 months ago #892

Anktiva can and will be used in combination with many therapies.... soon as first line but also as many other therapies fail

frank fager IBRX 4 months ago #893

Glad I have a long term perspective and have no interest in penny flipping.
$12-$15 in 1 year $25 in 2 years $50-$100 in 5 years

frank fager IBRX 4 months ago #894

Dr PSS will be on Sean Spicer Friday 🤞 maybe something big will be discussed

frank fager IBRX 4 months ago #895

"IMMUNITYBIO has gone from a small cap spec
To a mid cap revenue generator"

Cramer agrees and then calls it a spec and of course mentions nothing about the pipeline and clinical trials going on. He is a performer. He has a degree in performing arts and law school at Harvard. So he is an actor and an unethical.......

frank fager IBRX 4 months ago #897

At some point quality dividend paying stock will do some catching up. Billions has chased very few stocks. I am sure the pros are already moving away from many and moving to bonds because rates will fall and other forgotten quality stocks.

frank fager IBRX 4 months ago #898

Why wouldn't Cramer say something like. ImmunityBio is an exciting company with a FDA and good chance more coming and Anktiva seems to have many many future uses. It reminds me of Mercks Keytruda but maybe better. Jim you are fired..... Merck spends billions advertising ImmunityBio spends ZERO. Clean out your desk you are finished.

frank fager IBRX 4 months ago #900

Cramer is a taking head for MSM propaganda, Wall Street and Big Pharma.

He should explain how a company with a patented treatment and a FDA approval in America and Europe is still a spec. It's an early stage biopharmaceutical company expanding sales and also will be expanding the use of it FDA approved Anktiva with time. He is a POS ass hole.